No data to show
XNAS
MDCX
Market cap42mUSD
Jun 16, Last price
2.66USD
1D
2.31%
1Q
-13.64%
IPO
0.38%
Name
Medicus Pharma Ltd
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-11m
CFO
-10m
Valuation
Title USD in thousands, except ratios and share amounts | FY |
|---|---|
| 2024‑12 | |
| Income | |
Revenues | |
Cost of revenue | 11,181 |
Unusual Expense (Income) | |
NOPBT | (11,181) |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | (11,181) |
Net income | (10,620) |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | 7,520 |
BB yield | |
| Debt | |
Debt current | 116 |
Long-term debt | 528 |
Deferred revenue | |
Other long-term liabilities | 123 |
Net debt | (3,520) |
| Cash flow | |
Cash from operating activities | (10,247) |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | 12,692 |
FCF | |
| Balance | |
Cash | 4,164 |
Long term investments | |
Excess cash | 4,164 |
Stockholders' equity | 1,614 |
Invested Capital | 1,843 |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | 9,619 |
Price | |
Market cap | |
EV | |
EBITDA | (11,181) |
EV/EBITDA | |
Interest | 318 |
Interest/NOPBT | |